Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 2/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | NCK1 | P16333 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2756741 | 1.00 | NQO2 (0.85) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL21131352 | 0.97 | NQO2 (0.81) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL4359997 | 0.92 | NQO2 (1.00) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL12355722 | 0.89 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL434975 | 0.89 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL12355721 | 0.89 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL30745612 | 0.89 | NQO2 (0.70) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL24277660 | 0.86 | NQO2 (0.65) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL404199 | 0.85 | NQO2 (0.64) | NQO2ALDH1A1KDM4EL3MBTL1MAPT | |
| SCHEMBL8443821 | 0.85 | NQO2 (0.64) | NQO2ALDH1A1KDM4EL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134165-A1 | COMPOSITION AND LIGHT EMITTING DEVICE CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-04 | — | — | US | disclosed |
| WO-2021160132-A1 | HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海美悦生物科技发展有限公司 | 2021-08-19 | — | — | WO | disclosed |
| CN-105884707-A | Diamine monomer containing triphenylamine-phenoxazine structure, preparation method and application of diamine monomer | 吉林大学 | 2016-08-24 | — | — | CN | disclosed |
| US-9139569-B2 | Fused tricyclic aryl compounds useful for the treatment of viral diseases | MERCK SHARP & DOHME CORP. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20120251491-A1 | FUSED TRICYCLIC ARYL COMPOUNDS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME LLC | 2012-10-04 | — | — | US | disclosed |
| US-20120211082-A1 | PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120211082-A1 | PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2463929-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL USING SAME | Mitsubishi Chemical Corporation (JP) | 2012-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120251491-A1 | FUSED TRICYCLIC ARYL COMPOUNDS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | HAVCR2, ZC3HAV1, AADAC | NQO2 2526/4885ALDH1A1 849/4885KDM4E 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.